Company profile
Stimcell Energetics, Inc.
OTC: STME · Healthcare · Medical - Devices
Canadian filerHQ Vancouver, BCCIK 0001493712Reports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 22GM —SS 33
v0.1 · 25/100 weight · pillars only
↑ growth stability, listing tenure · ↓ workforce scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$566.3k
Employees
1
as of 2026-08-23
Market cap
$4.0M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02024
Net income-$566.3k-$566.3k2025
Total assets$21.2k$21.2k2025
Liabilities$1.3M$1.3M2025
Equity-$1.2M-$1.2M2025
Revenue trend
FY2012 – FY2024 · USD
FY12
FY12
FY17
FY17
FY20
FY20
FY24
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Stimcell Energetics, Inc.’s revenue?
Stimcell Energetics, Inc. booked $0 in FY2024 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
ENDRA Life Sciences Inc.25DWEED, Inc.19DMustang Bio, Inc.41DPharmaTher Holdings Ltd.——Quest PharmaTech Inc.——nDatalyze Corp.47DKey facts
CEODavid Jeffs
SectorHealthcare
IndustryMedical - Devices
HeadquartersVancouver, BC
ExchangeOTC: STME
Employees1
IPO date2013-08-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.